Invention Grant
- Patent Title: D3 dopamine receptor agonists to treat dyskinesia in Parkinson's disease
-
Application No.: US15497287Application Date: 2017-04-26
-
Publication No.: US10543180B2Publication Date: 2020-01-28
- Inventor: Sandhya Kortagere , Eldo V. Kuzhikandahil
- Applicant: DREXEL UNIVERSITY , RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
- Applicant Address: US PA Philadelphia US NJ New Brunswick
- Assignee: Drexel University,Rutgers, The State University of New Jersey
- Current Assignee: Drexel University,Rutgers, The State University of New Jersey
- Current Assignee Address: US PA Philadelphia US NJ New Brunswick
- Agency: Saul Ewing Arnstein & Lehr LLP
- Agent Kathryn Doyle; Domingos J. Silva
- Main IPC: A61K31/137
- IPC: A61K31/137 ; A61K45/06 ; A61K31/198 ; A61K31/4045 ; A61K31/428 ; A61K31/473 ; A61K31/48 ; A61K31/506 ; A61K31/519 ; A61K31/5513 ; A61K31/4184 ; C07C211/29 ; C07C215/08 ; C07C215/54 ; C07C217/62 ; C07D209/14 ; C07D235/16 ; C07D471/04
Abstract:
The present invention provides a method of inhibiting, suppressing or preventing levodopa-induced dyskinesia in a patient suffering from Parkinson's Disease, comprising the step of administering to the patient a pharmaceutical composition comprising at least one compound of the invention. The present invention further provides a method of inhibiting, suppressing or preventing Parkinson's Disease in a patient, comprising the step of administering to the patient a pharmaceutical composition comprising at least one compound of the invention.
Public/Granted literature
- US20170246128A1 NOVEL D3 DOPAMINE RECEPTOR AGONISTS TO TREAT DYSKINESIA IN PARKINSON'S DISEASE Public/Granted day:2017-08-31
Information query
